Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Menkes Disease - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. Menkes Disease is an X-linked recessive ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Menkes disease - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Menkes Disease - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. Menkes Disease is an X-linked recessive ...

The US Food and Drug Administration (FDA) has accepted for filing and priority review of the new drug application (NDA) for Sentynl Therapeutics' CUTX-101 (copper histidinate) for the treatment of ...

(RTTNews) - Sentynl Therapeutics and Fortress Biotech, Inc. (FBIO), a biopharmaceutical company, on Monday, announced that the U.S. Food and Drug Administration has accepted for filing and granted ...

("Cyprium”), today announced the acceptance for review of the New Drug Application ("NDA”) by the U.S. Food and Drug Administration ("FDA”) for CUTX-101 (Copper Histidinate) for the treatment of ...